Expression of Killer Immunoglobulin Receptor Genes among HIV-Infected Individuals with Non-AIDS Comorbidities

Table 1

Demographic and clinical characteristics of study participants.

		%
Gender ()
Male	87	82.9
Female	18	17.1
Age in years ()
25-44	42	40
45-59	44	41.9
≥ 60	19	18.1
Sexual history ()
Heterosexual	54	52.9
MSM	33	32.4
Bisexual	14	13.7
HIV route of transmission ()
Unprotected sex	72	68.6
Shared needle/syringe	7	6.7
Others	7	6.7
Duration of HIV infection ()
< 5 years	9	10.3
5-10 years	40	38.8
> 10 years	54	52.4
Duration of cART ()
< 5 years	16	15.2
5-10 years	42	40
> 10 years	47	44.8
cART regimen ()
NRTI + NNRTI	47	46.1
NRTI + INSTI	47	46.1
Others (PI + NRTI and/or NNRTI)	8	7.8
≥ 1 non-AIDS associated comorbidities ()	44	41.9
Hypertension	31	29.5
Hyperlipidemia	31	29.5
CVD	10	9.5
Diabetes	9	8.6
Non-cART medication ()
Antihypertensives	31	29.5
Lipid-lowering agents	31	29.5
Hypoglycaemic agents	9	8.6

MSM: men exclusively having sex with men; cART: combined antiretroviral therapy; NRTI: nucleoside/nucleotide reverse-transcriptase inhibitor; NNRTI: nonnucleoside reverse-transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor.